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Every asparagine in every protein undergoes nonen-
zymatic deamidation to aspartate or isoaspartate at a
rate determined by the surrounding protein structure
and cellular environment. Under physiologic condi-
tions, the deamidation half-life of individual as-
paragines in proteins is proposed to range from less
than a day to several centuries. More than 200 pro-
teins have been shown to undergo deamidation to a
meaningful degree, and modeling predicts that hun-
dreds more undergo deamidation at rates that have
the potential to be of biological consequence. Be-
cause deamidation converts an asparagine into an
aspartate or isoaspartate, it introduces a negative
charge into a protein and results in the isomerization
of a residue. Therefore, deamidation has the poten-
tial to change protein function. Additionally, deami-
dation is thought to render some proteins more sus-
ceptible to degradation. In most instances in which
asparagine deamidation has been identified in vivo,
it is involved in pathology. Hence, deamidation has
been viewed primarily as a form of protein damage.
However, the pervasiveness and evolutionary persis-
tence of these unstable asparagines suggest that
they may have a beneficial role. Notably, the change
of even a single neighboring amino acid can have a
marked effect on the rate of deamidation of an as-
paragine. Therefore, the underlying rate of deamida-
tion of any asparagine is genetically programmable.
This characteristic, combined with the wide range of
deamidation rates that can be programmed, imparts
to asparagines the potential to serve as molecular
timers that regulate protein function and stability.
Nonenzymatic Asparagine DeamidationPurification
Artifact or in Vivo Process
The deamidation of an asparagine residue in a eukaryotic cell is
a nonenzymatic process that is initiated by a nucleophilic attack
of the peptide bond amino group on the asparagine side-chain
amide group. This results in the formation of a cyclic succin-
imide intermediate that is hydrolyzed to either an aspartate or
an isoaspartate residue, with a preference for the formation of
the latter because of the asymmetry of the succinimide interme-
diate (Fig. 1). Therefore, deamidation introduces a negative
charge into a protein and results in the isomerization of a
residue. Glutamine, the other amino acid with an amide side
chain, can also undergo spontaneous deamidation, but this
occurs at a much slower rate than does the deamidation of
asparagine (1), so it is likely that nonenzymatic glutamine
deamidation is not of the same biological importance as
asparagine deamidation. Similarly, aspartate can undergo spon-
taneous isomerization to isoaspartate (Fig. 1), but this also
occurs at a slower rate and at fewer sites than asparagine deami-
dation (1), so it is not likely to be of the same importance.
It was found that asparagine has a propensity to spontaneous-
ly undergo deamidation under mild conditions, at least as early
as 1883, by Schulze and Bosshard (2); however, the deamidation
of asparagine in proteins was considered nothing more than a
purification artifact until the 1960s, when Flatmark and col-
leagues demonstrated in an elegant series of experiments that cy-
tochrome c becomes deamidated in vivo (3, 4). They first found
that there are four electrophoretic variants of monomeric cy-
tochrome c in bovine heart isolates, which they designated Cy I,
Cy II, Cy III, and Cy IV, in order of their decreasing mobility
during electrophoresis. They then demonstrated that the major
component, Cy I, is spontaneously converted to Cy II, Cy III,
and Cy IV in a physiologic buffer. Finally, they found that the
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Fig. 1. Deamidation results in the conversion of asparagine to as-
partate or isoaspartate. A succinimide intermediate is formed
when asparagine is deamidated. The intermediate is then rapidly
hydrolyzed to either an aspartate or an isoaspartate. Isoaspartate
can also be formed through the isomerization of aspartate.
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four variants differ only in the number of amide groups they
contain, with Cy II, Cy III, and Cy IV containing fewer amide
groups than Cy I, which indicates that Cy I is native cytochrome
c, and Cy II, C III, and C IV are deamidated forms of Cy I.
Hence, Flatmark had demonstrated that deamidation of cy-
tochrome c occurs spontaneously under physiologic conditions.
Flatmark and his colleague Sletten then sought to determine
whether cytochrome c becomes deamidated in vivo (4). They
found that the same four variants of cytochrome c identified in
bovine heart are present in multiple organs of the rat. Notably,
the relative concentration of each of the variants was the same
in all of the organs examined, and the relative concentration of
each was the same regardless of whether they extracted the cy-
tochrome c from tissue using either of two different solvents in
which the rate of deamidation would differ (dilute sulfuric acid
at pH 4.0 or distilled water). These findings argued strongly that
the deamidated forms of cytochrome c did indeed form in vivo,
but Flatmark and Sletten provided conclusive proof of this with
a final, particularly elegant experiment (Fig. 2). They first in-
jected rats with 59Fe to label newly synthesized cytochrome c
and then, beginning 72 hours later, they administered daily in-
jections of unlabeled iron sorbitol. The unlabeled iron acted to
block the incorporation of 59Fe into the cytochrome c that was
synthesized after the first 72 hours. These experiments indicat-
ed that 59Fe-labeled Cy I (native form) increased rapidly and
then decreased continuously after approximately the first 72
hours. However, as the concentration of 59Fe-labeled Cy I de-
creased, the concentration of 59Fe-labeled Cy II and Cy III
(deamidated forms) continued to increase relative to the amount
of 59Fe-labeled Cy I over the 28 days of the study. The simplest
explanation for these results is that Cy I was continuously
deamidated to Cy II and Cy III in vivo. Had the deamidation of
cytochrome c occurred only during the purification process, the
ratio of the 59Fe-labeled Cy II and Cy III relative to 59Fe-labeled
Cy I would have been the same at all intervals.
The Molecular Clock Hypothesis of Deamidation
After hearing of Flatmark’s studies, a graduate student, Arthur
Robinson, questioned why such an exquisitely unstable amino
acid as asparagine would be so widely distributed in nature un-
less its deamidation had a beneficial role (5). Robinson consid-
ered Flatmark’s finding that each of the deamidation products
of native cytochrome c are present at differing concentrations,
but that the relative concentrations of each vary little from tis-
sue to tissue or species to species (4), and postulated that each
asparagine in a protein must become deamidated at a rate that is
inherent for that particular asparagine. On the basis of this con-
cept, he proposed that asparagine deamidation could play the
role of a timer of biological events, with the rate largely set by
the primary, secondary, and tertiary structure of the protein sur-
rounding each deamidation site. In this manner, the duration of
certain biological processes could be set to occur at a specific
rate simply by varying the amino acids that surround asparagine
residues within proteins (5). Since then, Robinson, members of
his family, and other colleagues have generated experimental
evidence to support this molecular clock hypothesis.
In 1970, Robinson and co-workers demonstrated that the rate
of asparagine deamidation can indeed be determined by the sur-
rounding amino acid sequence. For example, in a pH 7.0 sodi-
um phosphate buffer at 37°C, the asparagine in the pentapeptide
Gly-Ala-Asn-Ala-Gly has a deamidation half-life of 40 days,
whereas the asparagine in the pentapeptide Gly-Arg-Asn-Arg-
Gly has a deamidation half-life of only 11 days (6). This varia-
tion in rate is due to both the steric and catalytic effects of
neighboring residues (7). Therefore, a change in a neighboring
residue can have a profound impact on the rate at which an as-
paragine becomes deamidated. This makes asparagine deamida-
tion an ideal candidate for a timer that can be genetically pro-
grammed to regulate biological events of various durations.
If deamidation does function as a molecular timer with the
rate of deamidation set by the neighboring amino acids, it
might be expected that asparagine-containing sequences that
function as useful timers would be selected for, whereas po-
tentially disruptive sequences (in other words, sequences that
undergo deamidation too rapidly) would be selected against.
Indeed, Robinson and co-workers found that, in a set of 43
proteins, certain amino acids were selected for as neighbors
of asparagine and glutamine residues, whereas others were
selected against (6). A subsequent analysis of all of the amino
acid pairs and triplets in a set of 1465 proteins and peptides
revealed that asparagine and glutamine are distributed in pro-
teins with a higher statistical preference for and rejection of
certain surrounding sequences than any of the 18 other amino
acids (8). These data suggested that there are sequences that
contain asparagines that form useful functional units and that
these are preferred, whereas other asparagine-containing se-
quences form disruptive units and are rejected. This is consis-
tent with the hypothesis that certain asparagines and their sur-
rounding sequences function together as molecular timers and
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Fig. 2. Deamidation occurs in vivo. Flatmark and Sletten (4) found
that there are four forms of monomeric cytochrome c in several
bovine and rat tissues. They demonstrated that one of these, Cy I,
is the native form of cytochrome c and that the others—Cy II, Cy
III, and Cy IV—are deamidated forms. To determine whether cy-
tochrome c becomes deamidated in vivo, they first delivered a
pulse of 59Fe intravenously to rats, and then, beginning 72 hours
later, they administered unlabeled iron sorbitol daily as a chase to
block the uptake of 59Fe into newly synthesized cytochrome c.
When the cytochrome c was isolated at an early time point, the
label was primarily found in Cy I. However, the level of labeled Cy
II and Cy III increased relative to the level of labeled Cy I at inter-
mediate and late time points.
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that only timers with certain deamidation rates can play a
useful role in timing biological events. That there are proteins
with deamidation half-times of less than a day provides evi-
dence for this hypothesis, as it is likely that such unstable
proteins would have been driven to a more stable form by
evolutionary pressure if deamidation were merely a form of
protein damage.
Because deamidation is irreversible, it would be expected
in general that asparagine- and glutamine-containing se-
quences with short deamidation half-lives would not be found
in long-lived proteins. Conversely, deamidation would only be
of consequence if it occurred within the lifetime of a protein,
and the summation of the deamidation of several amide-
containing residues could serve to time short intervals. A
comparison of the total number of asparagines and glutamines
in long-lived and short-lived proteins demonstrated a clear in-
verse correlation between the number of amide-containing
amino acids in a protein and the known lifetime of the protein
(9). This finding was consistent with a role for asparagine
deamidation as an embedded clock that functions during the
lifetime of a protein.
It is now clear that in addition to the primary structure, the rate
of asparagine deamidation is controlled by the secondary and ter-
tiary structure of the protein (10). A corollary to this is that the
rate of deamidation of an asparagine can be altered by a change in
secondary or tertiary structure such as might occur if the protein is
subject to a posttranslational modification or a change in the
interaction with a binding partner (10). Therefore, even though
the underlying deamidation rate is set by the protein sequence sur-
rounding the asparagine that undergoes deamidation, the process
is subject to multiple levels of control within the protein.
The rate of deamidation is also determined by the cellular
environment. For instance, the rate of deamidation of cyto-
chrome c is altered by changes in pH—even a small change in pH
within the range of pH 7.0 to 8.0 can alter the rate of cytochrome
c deamidation (3). The rate of deamidation is also determined by
the ionic composition and ionic strength of the buffer and the
temperature (3). Therefore, the rate of deamidation can be regu-
lated by changes in the cellular environment (Fig. 3).
Robinson and his son, Noah Robinson, devised a computa-
tional method for predicting the deamidation half-life of any as-
paragine in any protein for which the three-dimensional (3D)
structure is known (11, 12). Their formula combines the ob-
served primary structure–determined deamidation rate with a
modifying component that is computed on the basis of the 3D
structure. Using this formula, which has proven to be extraordi-
narily accurate, they demonstrated that deamidation must be
widespread. They first computed the predicted deamidation
half-life of 126 human proteins included in the Brookhaven
Protein Data Bank and found that 4% of these proteins would
be predicted to have a single-site deamidation half-life of less
than 1 day, and 13% would be predicted to have a single-site
deamidation half-life of less than 5 days when incubated in a
physiologic phosphate buffer (10). They then computed the pre-
dicted deamidation half-lives for all of the asparagines in the 49
Drosophila proteins for which 3D structures were registered in
the Protein Data Bank. The deamidation half-lives of these pro-
teins were predicted to range from 1 day to more than 1000
days. Fifteen were predicted to have deamidation half-lives
shorter than the intrinsic Drosophila life span of 50 days, and of
these, five were predicted to have deamidation half-lives of less
than 5 days (13). The findings were similar when they comput-
ed the predicted deamidation rates of all 17,935 proteins that
were listed in the Protein Data Bank (13). These results predict
that deamidation is widespread.
There is also direct evidence that deamidation is widespread.
As outlined above, deamidation of asparagine gives rise to as-
partate and isoaspartate, with isoaspartate as the major product
because of the asymmetry of the succinimide intermediate. The
ubiquitously expressed enzyme protein L-isoaspartyl methyl-
transferase (PIMT) is said to partially “repair” deamidated pro-
teins because it catalyzes the conversion of isoaspartate to
aspartate (1). In the PIMT knock-out mouse, isoaspartate abun-
dance at birth throughout most of the tissues is four to eight
times its abundance in the tissues of wild-type mice (14, 15),
which indicates that deamidation occurs ubiquitously even in
the tissues of young, otherwise healthy, mice. Because PIMT is
expressed in every organism from bacteria to humans, these
findings strongly suggest that deamidation is a ubiquitous pro-
cess in the tissues of a wide range of organisms. Because as-
paragine deamidation can be genetically suppressed by a single
amino acid change in the adjacent sequence, its pervasiveness
argues that it must have a beneficial role.
Asparagine Deamidation as a Timer of Protein
Turnover
It was first proposed that deamidation could serve as a timer
that determines the life span of a protein because it was found
that the deamidated forms of cytochrome c have a more “open”
structure, which imparts increased susceptibility to proteolysis
(6, 16). Indeed, rabbit muscle aldolase undergoes deamidation
at a single site that has an in vivo deamidation half-life that is
similar to the in vivo half-life of the protein (17). This suggests
that deamidation at a single site regulates the protein’s turnover.
R E V I E W
Fig. 3. The rate of deamidation is regulated by multiple factors.
The inherent rate of deamidation of an asparagine in a protein is
determined by the surrounding sequence (6). However, the rate
can be modified by the secondary and tertiary structure of the
protein (10), as well as by the pH, ionic composition and strength,
and temperature of the environment (3). The enzyme PIMT cat-
alyzes the isomerization of isoaspartate, the major asparagine
deamidation product, to aspartate (1).
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Moreover, the rate of deamidation of a pentapeptide that corre-
sponds to the asparagine-containing carboxyl peptide of rabbit
muscle aldolase has a deamidation half-life of 6.4 days in a
physiologic buffer (18), a rate that is similar to the in vivo
deamidation half-life and protein half-life of 8 days. This sug-
gests that the rate of turnover of rabbit muscle aldolase is deter-
mined by a molecular timing unit formed by a single asparagine
and its surrounding sequence.
Similar amide timing units also regulate cytochrome c
turnover, albeit in a more complex manner. By comparing the in
vitro deamidation rate of a corresponding peptide, it was deter-
mined that the deamidation of the C-terminal sequence
Thr-Asn-Glu, the first cytochrome c deamidation, is sequence-
controlled. This deamidation apparently leads to a change in the
3D structure of cytochrome c that accelerates the rate of the
second deamidation. This second deamidation correlates with
the onset of cytochrome c degradation (4, 19, 20). Therefore,
for some proteins, the rate of deamidation correlates with the
rate of protein turnover, which suggests that deamidation can
function as a timer that regulates turnover. To our knowledge,
however, this has never been assessed directly.
Regulation of the Rate of Asparagine Deamidation by
Changes in Intracellular pH
The Bcl-2 family of proteins, which regulates the cellular re-
sponse to apoptotic stimuli, is composed of both proapoptotic
and antiapoptotic proteins (21). There is strong evidence that the
antiapoptotic Bcl-2 protein Bcl-xL has a primary role in deter-
mining cellular susceptibility to antineoplastic therapy (22). It
was first noted by Aritomi and co-workers that Bcl-xL undergoes
deamidation in vitro (23). Subsequently, it was found that Bcl-xL
is deamidated at Asn52 and Asn66 in vivo and that the rate of
deamidation of Bcl-xL increases in response to treatment with
DNA-damaging antineoplastic agents in susceptible tumor cells
(24). Deamidation of Bcl-xL increases cellular susceptibility to
apoptosis [(24); see erratum (25)]. Because deamidation is a rel-
atively slow process, Bcl-xL deamidation could serve as chrono-
metric buffer that affords the cell time to repair low-level DNA
damage before it becomes committed to undergo apoptosis (24).
Bcl-xL is the first known example of a protein in which the
rate of deamidation is regulated by cellular signaling. The rate
of Bcl-xL deamidation increases with increasing pH (24), and
the two Bcl-xL asparagines that become deamidated are pre-
dicted to undergo nonenzymatic Bcl-xL deamidation rapidly at
pH 7.4 (11, 24). Additionally, a small change in pH between
pH 7.0 and 8.0 can substantially increase the rate of deamida-
tion of a protein (3). These findings are notable because there
is an increase in pH to as high as pH 8.0 early in several forms
of apoptosis, including DNA damage–induced apoptosis
(25–30). The increase in pH is mediated by the protein Na+/H+
exchanger 1 (NHE1), a ubiquitously expressed protein that
regulates cytosolic pH (25–29). Together, these f indings
strongly suggest that the increased rate of Bcl-xL deamidation
that occurs in response to DNA damage is stimulated by the
NHE1-mediated increase in cytosolic pH (Fig. 4), and indeed,
this has recently been confirmed (31). Therefore, asparagine
deamidation can serve as a timer that varies in rate in response
to changes in the cellular environment. It is likely that alter-
ations in pH or other solvent properties of the cellular envi-
ronment regulate the rate of deamidation of other proteins, as
well as that of Bcl-xL.
Asparagine Deamidation May Serve as Timer of
Chromatin Remodeling
Eukaryotic DNA is packaged into chromatin primarily through
its interaction with histone proteins. DNA is wrapped around
the core histones to form nucleosomes (32). A linker histone,
histone H1, locks the DNA in position at the nucleosome entry
and exit sites to enable the formation of higher-order chromatin
structure (33). Posttranslational modifications of histones regu-
late chromatin structure and function (32); therefore, histones
have a primary role in the regulation of gene expression.
There are several subtypes of histone H1 (33). One of these,
histone H1°, is primarily found in nonproliferating, terminally
differentiated cells (34). In such cells, histones are thought to
remodel chromatin to suppress transcription. Histone H1° ex-
ists in liver and brain in two to four subfractions; the relative
proportion of each varies with age (35, 36). These subfractions
are made up of native histone H1°, histone H1° that is acetylat-
ed at the N terminus, and histone H1° that is deamidated at
Asn3 and either acetylated or unacetylated at the N terminus
(35, 36). The abundance of the deamidated forms of histone
H1° is 1.6- to 4-fold as high in the livers and 8- to 12-fold as
high in the brains of 10-month-old rodents, respectively, com-
pared with those of 20-day-old rodents (36). The authors specu-
lated that increased abundance of the deamidated forms in the
older tissue might have a functional role in the chromatin re-
modeling that suppresses transcription in aging tissue. In this
role, deamidation of histone H1° would serve as a time-
dependent switch to decrease transcription in aging cells.
R E V I E W
Fig. 4. DNA damage activates NHE1 to alkalinize cytosolic pH,
which increases the rate of Bcl-xL deamidation. Bcl-xL is nonenzy-
matically deamidated at Asn52 and Asn66. The rate of deamidation
is increased in susceptible tumor cells that are treated with DNA-
damaging antineoplastic agents (24). Deamidation of Bcl-xL de-
creases cellular Bcl-xL antiapoptotic activity [(24); see erratum
(25)]. The NHE1-mediated early increase in cytosolic pH that oc-
curs in DNA damage–induced and other forms of apoptosis
(26–30) mediates the increased rate of Bcl-xL deamidation (31).
The mechanism by which DNA damage activates NHE1 is un-
known at present.
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Asparagine Deamidation as a Timer in the Activation
of Cell-Matrix Interactions
Fibronectin is an extracellular matrix protein that has important
roles in cell adhesion, migration, growth, and differentiation
(37). Fibronectin contains two highly conserved Gly-Asn-Gly-
Arg-Gly (NGR) loops, which had been suggested to have a role
in integrin-mediated cell-fibronectin interactions (38). Curnis
and colleagues found that fibronectin aging increases cell-
fibronectin interactions because of the deamidation of the as-
paragine in an NGR loop (39). Generation of an isoaspartate at
the deamidation site in the NGR loop is necessary to promote
the interaction, and consequently, treatment with PIMT, the en-
zyme that converts isoaspartate to aspartate, decreases adhe-
siveness. These findings are notable because isoaspartate had
previously been thought to have a generalized inactivating func-
tion. Thus, Curnis and colleagues identified the first example of
activation by isoaspartate formation. They speculated that
deamidation of the NGR sequence could act as molecular timer
for activating latent integrin-binding sites. It is possible that the
NGR loop remains in its inactive form until the fibronectin is
secreted from the cell to avoid spurious interactions. It could be
activated in a time-dependent manner or it could be kept inac-
tive by PIMT until it is secreted.
Asparagine Deamidation in DiseaseDysregulation
of a Normal Process?
Despite the evidence of its role in regulation of some normal
cellular processes, asparagine deamidation continues to be near-
ly universally viewed as a form of protein damage. This is in
part because it is known mostly for its role in pathological con-
ditions. The two most well-studied examples are cataractogene-
sis (the formation of cataracts) and Alzheimer’s disease.
Cataractogenesis is thought to be a result of accumulation of in-
soluble aggregates and cross-linked products of the different
forms of crystallins (40). Deamidation of crystallin is one of the
most common posttranslational modifications that occur during
cataract formation (41, 42). Recently, it was demonstrated that
crystallins in which asparagines are replaced with aspartates to
mimic deamidation aggregate to a much larger extent than do
wild-type crystallins and display other characteristics that are
associated with cataract formation. These findings suggest an
etiologic role for deamidation in cataractogenesis (43, 44).
Similarly, it is thought that deamidation has a role in develop-
ment of the neurofibrillary tangles that are pathognomonic for
Alzheimer’s disease. Neurofibrillary tangles are composed of
units called paired helical filaments (45). There is evidence that
these develop because of deamidation of the microtubule-binding
domain of the tau protein (46). It has been proposed that iso-
aspartate formation at these sites causes a conformational
change that supports self-assembly of the tau protein into paired
helical filaments, which suggests that deamidation has a basic
role in Alzheimer’s disease (47).
Although it is likely that deamidation plays a role in catarac-
togenesis and Alzheimer’s disease, it is not clear that it should,
therefore, be viewed simply as a form of protein damage when
it is found to contribute to disease. Instead, the deamidation that
contributes to certain pathologic conditions may represent the
dysregulation of a normally beneficial process. The dysregula-
tion of many beneficial posttranslational modifications results
in pathology. One of the clearest examples of this is phosphory-
lation dysregulation in tumorigenesis. An increase in cyclin-
dependent kinase activity and the resultant increased phospho-
rylation of its effector proteins is required for the generation of
many types of tumors (48); however, this increase in phospho-
rylation is not viewed as a form of protein damage. It could
very well be that deamidation has a role in the normal function
or regulation of crystallin proteins or the tau protein, but that
it becomes dysregulated in cataractogenesis and Alzheimer’s
disease. It is possible that there is a change in the environment
of the protein, such as an increase in pH, that increases the rate
of deamidation or there could be a decrease in the clearance of
proteins that normally become deamidated. Alternately, there
could be a change that alters the manner in which the deamidated
molecules interact.
Consistent with the hypothesis that the dysregulation of
deamidation leads to pathology are the results of a study on the
role of the enzyme PIMT in determining Drosophila life span
(49). Ubiquitous overexpression of PIMT in Drosophila has no
effect on life span at 25°C; at 29°C, however, although the in-
creased temperature shortened the life span of both the control
and PIMT-overexpressing Drosophila, flies overexpressing
PIMT lived 35% longer than controls. One possible explanation
for this is that, at 29°C, there is an increased rate of deamidation
in both the control and PIMT-overexpressing flies and that over-
expression of PIMT can, in part, compensate for the increased
isoaspartate formation by catalyzing its conversion to aspartate
(49). It is possible that the increase in deamidation at 29°C rep-
resents the dysregulation of a normally beneficial process.
Conclusion
Deamidation is a widely occurring posttranslational modifica-
tion. This is most evident in mice in which the gene for the en-
zyme PIMT has been knocked out. At birth, these mice have
amounts of isoaspartate throughout most of their tissues four to
eight times those in the tissues of wild-type mice. Despite its
widespread occurrence, asparagine deamidation has remained
an obscure and understudied posttranslational modification.
Indeed, at the time this Review was written, fewer than 30 refer-
ences concerned with the physiologic function of asparagine
deamidation in eukaryotes were listed in PubMed. This lack of
attention is most likely because deamidation has primarily been
thought of as a spontaneous, unregulated form of protein dam-
age that is most closely associated with pathological conditions.
However, deamidation rates are not unregulated, but genetically
programmed, and the programmed rate can be modified through
signal transduction pathways, as occurs with DNA
damage–induced Bcl-xL deamidation. From the examples cited
in this review, it is clear that asparagine deamidation has the
potential to regulate several processes; it is possible that deami-
dation has a role in the regulation of a multitude of processes.
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